NCT05675410 2026-06-03A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and NivolumabNational Cancer Institute (NCI)Phase 3 Recruiting1,875 enrolled